DaVita (NYSE:DVA) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS

DaVita (NYSE:DVA) issued its quarterly earnings results on Thursday. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10, Zacks reports. DaVita had a return on equity of 88.18% and a net margin of 6.53%.

DaVita Stock Performance

Shares of NYSE DVA traded up $5.45 during midday trading on Thursday, hitting $177.45. The company’s stock had a trading volume of 1,001,902 shares, compared to its average volume of 577,411. The firm has a market cap of $14.55 billion, a P/E ratio of 19.14, a P/E/G ratio of 0.84 and a beta of 0.94. DaVita has a 1-year low of $118.56 and a 1-year high of $179.60. The firm’s fifty day moving average price is $161.15 and its 200-day moving average price is $157.11. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.

Wall Street Analyst Weigh In

Separately, Barclays increased their target price on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $161.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.